Please sign in with your existing account details.
Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.
Privacy statement - Terms and conditions
Forgotten your password?
You have exceeded the maximum number of login attempts for this email address and your account has been locked. An email has been sent to member of Browne Jacobson's web team and some one will be contacting you over the next two working days with details of how to change your password.
Are you sure you want to remove this item from you pinned content?
The publication of the school league tables has revealed that just 1 in 6 pupils in English secondary schools have achieved the new GCSE performance measure – the English baccalaureate (E-bac).
The Government’s recent White Paper proposed the introduction of the E-bac which requires pupils to achieve A2-C in English, Maths, Science, a Language and a Humanities subject.
The E-bac has angered many Head Teachers, not least because the standard has been applied retrospectively and many schools have slipped down the league tables as a result. There is concern that pressure for schools to perform in league tables will jeopardise student choice.
The Government is keen to discourage pupils from taking “less challenging” courses and a renewed focus on traditional subjects like History and Geography could help more students be admitted to the best universities. But there are surely many students who would rather have the freedom to study a non-E-bac yet valuable subject like ICT and be more than happy to side-step the £27,000 bill for university…
With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.
View blog
The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.
Our top tips for supporting transgender and non-binary pupils.
On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.
Senior Associate
Select which mailings you would like to receive from us.
Sign up